JP2009538340A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009538340A5 JP2009538340A5 JP2009512278A JP2009512278A JP2009538340A5 JP 2009538340 A5 JP2009538340 A5 JP 2009538340A5 JP 2009512278 A JP2009512278 A JP 2009512278A JP 2009512278 A JP2009512278 A JP 2009512278A JP 2009538340 A5 JP2009538340 A5 JP 2009538340A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- composition
- con
- carbon atoms
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 Cc1nnn[n]1* Chemical compound Cc1nnn[n]1* 0.000 description 3
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80304006P | 2006-05-24 | 2006-05-24 | |
| US60/803,040 | 2006-05-24 | ||
| PCT/US2007/069516 WO2007140197A1 (en) | 2006-05-24 | 2007-05-23 | Therapeutic pyrrolidine compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009538340A JP2009538340A (ja) | 2009-11-05 |
| JP2009538340A5 true JP2009538340A5 (enExample) | 2010-07-08 |
| JP5552311B2 JP5552311B2 (ja) | 2014-07-16 |
Family
ID=38523446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009512278A Expired - Fee Related JP5552311B2 (ja) | 2006-05-24 | 2007-05-23 | 治療用ピロリジン化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7550448B2 (enExample) |
| EP (1) | EP2019820B1 (enExample) |
| JP (1) | JP5552311B2 (enExample) |
| AU (1) | AU2007267620B2 (enExample) |
| BR (1) | BRPI0712500A2 (enExample) |
| CA (1) | CA2653223C (enExample) |
| WO (1) | WO2007140197A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7550448B2 (en) * | 2006-05-24 | 2009-06-23 | Allergan, Inc. | Therapeutic compounds |
| US7964596B2 (en) * | 2008-03-07 | 2011-06-21 | Allergan, Inc. | Therapeutic compounds |
| JP2012508225A (ja) | 2008-11-10 | 2012-04-05 | ファイザー・リミテッド | ピロリジン |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| US5462968A (en) | 1994-01-19 | 1995-10-31 | Allergan, Inc. | EP2 -receptor agonists as agents for lowering intraocular pressure |
| US5902726A (en) | 1994-12-23 | 1999-05-11 | Glaxo Wellcome Inc. | Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma |
| ES2337887T3 (es) * | 2001-12-20 | 2010-04-30 | Merck Serono Sa | Derivados de pirrolidina en calidad de moduladores de prostaglandina. |
| US7053085B2 (en) | 2003-03-26 | 2006-05-30 | Merck & Co. Inc. | EP4 receptor agonist, compositions and methods thereof |
| US7550448B2 (en) * | 2006-05-24 | 2009-06-23 | Allergan, Inc. | Therapeutic compounds |
| US7498447B2 (en) * | 2006-05-24 | 2009-03-03 | Allergan, Inc. | Therapeutic compounds |
-
2007
- 2007-05-11 US US11/747,490 patent/US7550448B2/en active Active
- 2007-05-23 EP EP07784061A patent/EP2019820B1/en not_active Not-in-force
- 2007-05-23 CA CA2653223A patent/CA2653223C/en not_active Expired - Fee Related
- 2007-05-23 BR BRPI0712500-3A patent/BRPI0712500A2/pt not_active IP Right Cessation
- 2007-05-23 AU AU2007267620A patent/AU2007267620B2/en not_active Ceased
- 2007-05-23 WO PCT/US2007/069516 patent/WO2007140197A1/en not_active Ceased
- 2007-05-23 JP JP2009512278A patent/JP5552311B2/ja not_active Expired - Fee Related
-
2009
- 2009-05-14 US US12/466,176 patent/US7786150B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009535426A5 (enExample) | ||
| JP2011500818A5 (enExample) | ||
| RU2007133581A (ru) | Замещенные гамма-лактамы в качестве терапевтических агентов | |
| JP2010530897A5 (enExample) | ||
| JP2007534702A5 (enExample) | ||
| JP2005526011A5 (enExample) | ||
| IL264541A (en) | History of sulfamolepyrolamide and their use as drugs for the treatment of jaundice b | |
| CA2755918C (en) | Oxadiazole derivatives | |
| JP2009536967A5 (enExample) | ||
| JP2013512277A5 (enExample) | ||
| CN1280561A (zh) | 酰胺基羧酸衍生物 | |
| JP2007500720A5 (enExample) | ||
| JP2009517502A5 (enExample) | ||
| JP2008514655A5 (enExample) | ||
| JP2004517813A5 (enExample) | ||
| JP2009535418A5 (enExample) | ||
| JP2005504011A5 (enExample) | ||
| JP2009538328A5 (enExample) | ||
| JP2012532106A5 (enExample) | ||
| JP2009538340A5 (enExample) | ||
| RU2014105895A (ru) | Терапевтические замещенные циклопентаны для уменьшения внутриглазного давления | |
| JP2012528813A5 (enExample) | ||
| EP2215084A2 (en) | Therapeutic substituted lactams | |
| JP2010507590A5 (enExample) | ||
| JP2011503089A5 (enExample) |